Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Assets Average: 2013-2025

Historic Assets Average for Ptc Therapeutics (PTCT) over the last 12 years, with Sep 2025 value amounting to $2.6 billion.

  • Ptc Therapeutics' Assets Average rose 40.42% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 40.42%. This contributed to the annual value of $1.8 billion for FY2024, which is 0.02% down from last year.
  • Per Ptc Therapeutics' latest filing, its Assets Average stood at $2.6 billion for Q3 2025, which was down 0.22% from $2.6 billion recorded in Q2 2025.
  • Ptc Therapeutics' Assets Average's 5-year high stood at $2.6 billion during Q2 2025, with a 5-year trough of $1.3 billion in Q3 2023.
  • In the last 3 years, Ptc Therapeutics' Assets Average had a median value of $1.8 billion in 2024 and averaged $1.9 billion.
  • Per our database at Business Quant, Ptc Therapeutics' Assets Average declined by 23.15% in 2023 and then skyrocketed by 44.67% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Assets Average (Quarterly) stood at $2.0 billion in 2021, then fell by 16.81% to $1.6 billion in 2022, then fell by 3.85% to $1.6 billion in 2023, then rose by 12.41% to $1.8 billion in 2024, then skyrocketed by 40.42% to $2.6 billion in 2025.
  • Its Assets Average was $2.6 billion in Q3 2025, compared to $2.6 billion in Q2 2025 and $2.2 billion in Q1 2025.